When a Hidden Illness Does Not Void the Claim: The 2015 Supreme Court Ruling on Unrelated Pre-Existing Disease

On 5 October 2015, a two-judge bench of the Supreme Court of India, comprising Justices Madan B Lokur and S A Bobde, decided Sulbha Prakash Motegaonkar v Life Insurance Corporation of India — a judgement that still governs how Indian insurers may treat the non-disclosure of a pre-existing illness (indiankanoon.org). The Life Insurance Corporation (LIC) had repudiated a death claim on the ground that the policyholder had not disclosed lumbar spondylitis when the policy was taken. The Court disagreed, and the principle it laid down on that date — that a concealed ailment unconnected to the actual cause of death cannot defeat a claim — is what this explainer unpacks.

The ruling matters because non-disclosure of a pre-existing disease is one of the most common reasons a life or health claim is turned down in India, and the four-week payment order the Court issued in 2015 gave families a clear precedent to cite. If you hold a term plan, an endowment policy or a health cover, the reasoning below tells you exactly when a hidden illness can, and cannot, be used against your nominees.

The Rule / Product

The dispute in Motegaonkar concerned a life insurance policy issued by LIC. The insured died of ischaemic heart disease and a myocardial infarction — a cardiac event. LIC, however, repudiated the claim by pointing to a different, undisclosed condition: lumbar spondylitis, a degenerative disorder of the lower spine that had no bearing on the heart. On 5 October 2015 the Supreme Court held that because the concealed ailment bore no nexus to the cause of death, the concealment was immaterial, and it directed LIC to pay the sum assured within four weeks (indiankanoon.org).

The case turns on a distinction the industry often blurs: not every non-disclosure is a material non-disclosure. A fact is material only if it would have influenced the insurer's decision to accept the risk or price it. The 2015 bench treated the causal link between the hidden condition and the eventual claim event as central — spondylitis of the spine simply could not explain a fatal cardiac episode, so its non-disclosure could not void the contract.

The statutory backstop for this reasoning is Section 45 of the Insurance Act, 1938, as substantially rewritten by the Insurance Laws (Amendment) Act, 2015 (indiacode.nic.in). Under the current Section 45, no life insurance policy may be called into question on any ground once three years have elapsed from the date of the policy, the date of commencement of risk, the date of revival, or the date of the rider, whichever is latest. Within that three-year window a policy can still be questioned — but only for fraud, or for a deliberate misstatement or suppression of a material fact, and the insurer must communicate the grounds in writing to the insured or the nominee.

Crucially, Section 45 also places the burden on the insurer. Where repudiation is on the ground of suppression of a material fact, the insurer must prove that the fact was within the policyholder's knowledge and was deliberately withheld. The Motegaonkar approach — asking whether the hidden fact was material to the claim at all — sits squarely within this framework, and the Insurance Regulatory and Development Authority of India (IRDAI) reinforces the same discipline through its Protection of Policyholders' Interests Regulations (irdai.gov.in).

Why It Matters

For a policyholder's family, the difference between a settled claim and a repudiated one is total: the entire sum assured is either paid or withheld. The 2015 ruling means an insurer cannot comb through medical records after a death, find an unrelated condition, and use it as a blanket reason to deny the money — the ailment must have a connection to the claim event.

That protection is significant given how India buys cover. A pre-existing disease can be anything diagnosed, treated, or showing symptoms before the policy start date, and it is the single largest trigger for claim disputes. After Motegaonkar, the mere existence of an undisclosed condition is not enough; the insurer must connect that condition to why the claim arose, or the repudiation fails the test the Supreme Court applied on 5 October 2015.

The judgement also complements the three-year rule in Section 45. Even where a death occurs within three years and the insurer alleges suppression, it must prove the fact was both material and deliberately hidden. Combined, these two shields — the statutory three-year cut-off and the judicial nexus test — mean a genuine claimant has strong ground to contest a mechanical repudiation, and can do so through the insurance ombudsman or the consumer forums without cost-heavy litigation.

If you are still deciding how much cover to hold, the size of the sum at stake is exactly why disclosure discipline is worth getting right. You can model an appropriate death benefit using Oquilia's term insurance premium calculator and human life value calculator, both of which let you scale cover to income and liabilities before you sign a proposal form.

Worked Numbers

The following figures are illustrative assumptions used only to show the arithmetic — plug your own numbers into the term insurance premium calculator for a real quote. Suppose a 35-year-old buys a term plan with a sum assured of Rs 1 crore and dies four years later of a cardiac event. Because more than three years have passed, Section 45 of the Insurance Act, 1938 bars the insurer from questioning the policy at all — the full Rs 1,00,00,000 is payable regardless of any unrelated condition later found in the medical file.

Now assume the same death occurs in year two, within the three-year window, and the insurer discovers an undisclosed spinal condition. Under the Motegaonkar nexus test decided on 5 October 2015, a spinal ailment cannot explain a cardiac death, so the concealment is immaterial and the Rs 1 crore claim still stands. The insurer would only have a defence if it could prove a material, deliberately suppressed fact connected to the cause of death.

The same logic reaches health insurance, where the arithmetic of a wrongful deduction is easy to see. Imagine a health policy with a sum insured of Rs 5,00,000 that caps the room rent at 1% of the sum insured, or Rs 5,000 a day, and the patient occupies a room costing Rs 10,000 a day. Because the chosen room is twice the cap, the insurer applies proportionate deduction: it settles only 50% of the associated medical charges. On a Rs 4,00,000 hospital bill, that turns a near-full settlement into a payout of roughly Rs 2,00,000 — a Rs 2,00,000 shortfall driven purely by a room-rent capping clause, not by any dispute over disclosure. You can stress-test cover sizing with the health insurance premium calculator before you commit.

Pitfalls

The Motegaonkar shield is powerful, but it does not cure the fine-print traps that quietly shrink a payout. The most damaging is the room-rent capping clause: as the Rs 2,00,000 shortfall above shows, exceeding a 1% daily cap can trigger proportionate deduction across the entire bill, not just the room charge.

A co-payment clause is a second trap. If a policy carries a 20% co-pay, the insured personally bears one-fifth of every admissible claim — on a Rs 5,00,000 hospitalisation, that is Rs 1,00,000 out of pocket, irrespective of how clean the disclosure was. Senior-citizen plans frequently embed such co-pays, so read the schedule before assuming full cover.

Disease-wise sub-limits are a third. A policy may cap cataract surgery at Rs 40,000 or a knee replacement at a fixed figure well below the sum insured, leaving the balance with the patient even when the claim is otherwise valid. These caps operate independently of the nexus test the Supreme Court set out on 5 October 2015.

Finally, timing traps persist despite Motegaonkar. A pre-existing disease waiting period still applies — treatment for a declared prior condition can be excluded for a defined period from inception — and a waiting period governs specified ailments in the early policy years. The judgement stops an insurer from using an unrelated hidden illness to void a claim; it does not switch off contractual waiting periods for the illness actually being treated, nor the eight-year moratorium framework that separately restricts non-disclosure defences after continuous cover. This mirrors the strict-reading discipline Oquilia has covered in the ECGC v Garg Sons exclusion-clause ruling and the Hindustan Safety Glass late-claim judgement.

FAQ

Does the Motegaonkar ruling mean insurers can never reject a claim for non-disclosure?

No. The 5 October 2015 judgement only bars repudiation where the concealed ailment has no nexus with the cause of the claim. Within the first three years, Section 45 of the Insurance Act, 1938 still lets an insurer contest a policy for fraud or a deliberately suppressed material fact, provided it communicates the grounds in writing.

What is the "nexus" test the Supreme Court applied?

The Court asked whether the concealed condition — lumbar spondylitis — was connected to the actual cause of death, which was ischaemic heart disease and myocardial infarction. Finding no link, it treated the non-disclosure as immaterial and, on 5 October 2015, ordered LIC to pay the sum assured within four weeks (indiankanoon.org).

How does Section 45 protect policyholders after three years?

Under Section 45 of the Insurance Act, 1938, as amended in 2015, no life policy can be called into question on any ground once three years have passed from the date of the policy, commencement of risk, revival, or rider, whichever is latest (indiacode.nic.in). After this period even a genuine non-disclosure cannot be used to deny the claim.

Does this 2015 life-insurance ruling also apply to health insurance?

The nexus principle is persuasive across insurance contracts, but health policies add their own protections: IRDAI's framework restricts non-disclosure defences after a continuous coverage moratorium, and disputes can be taken to the insurance ombudsman (irdai.gov.in). Contractual waiting periods for the treated illness still apply separately.

What should I disclose when buying a policy?

Declare every diagnosed condition, past treatment, and known symptom on the proposal form, however minor it seems. Full disclosure removes the insurer's ability to allege suppression within the three-year Section 45 window, and it is the surest way to keep a future claim outside dispute.

If my claim is wrongly repudiated, where do I complain?

Escalate first to the insurer's grievance cell, then to the Insurance Ombudsman, whose office is established under IRDAI's framework (irdai.gov.in); consumer forums remain open too, as the Motegaonkar claimant showed by pursuing the matter up to the Supreme Court in 2015.

Does a pre-existing disease waiting period still apply after this ruling?

Yes. The 5 October 2015 judgement addresses unrelated hidden illnesses; it does not remove a policy's pre-existing disease waiting period for the condition actually being treated. Check your schedule for the exact exclusion period before assuming a chronic condition is covered.